Na Song
Key Laboratory Of Precision Diagnosis And Treatment Of Gastrointestinal Tumors
Shenyang, 110001, China
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The safety and efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review.
Journal: Frontiers in immunology
Published: August 17, 2025
Unravelling Resistance: Integrating Metabolism, Epigenetics, Immunology, and Proteostasis in Strategies against Kirsten Rat Sarcoma Viral Oncogene Homolog-mutant Colorectal Cancer.
Journal: International journal of biological sciences
Published: June 04, 2025
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study.
Journal: Frontiers in immunology
Published: August 15, 2024
Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis.
Journal: Genes & diseases
Published: October 02, 2023
FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.
Journal: Annals of translational medicine
Published: March 12, 2021
Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison.
Journal: Journal of gastrointestinal oncology
Published: September 21, 2020
Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy.
Journal: Annals of translational medicine
Published: May 02, 2020
Biological and clinical significance of flap endonuclease‑1 in triple‑negative breast cancer: Support of metastasis and a poor prognosis.
Journal: Oncology reports
Published: March 19, 2020
PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells.
Journal: Medical oncology (Northwood, London, England)
Published: February 17, 2020
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma.
Journal: Investigational new drugs
Published: April 17, 2019
DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer.
Journal: Cancer management and research
Published: January 15, 2019
Last Updated: 09/26/2026